ALK announces acquisition of Bio-Medical Services

Published on February 12, 2014 at 1:01 PM · No Comments

ALK, the world's leading allergen extract manufacturer, announces the acquisition of Bio-Medical Services, a veterinary reference laboratory who pioneered in vitro serum IgE allergy testing in the veterinary industry.

Since 1923, ALK has exemplified scientific leadership in the field of allergy research, and has remained committed to the treatment of allergic disease in humans. Bio-Medical Services introduced in vitro serum IgE allergy testing to the veterinary industry in 1989, and has a proven track record for treating allergic disease for dogs, cats and horses. With this acquisition, ALK is now positioned to expand its allergy focus to include the very important veterinary allergy market.

"Joining forces with ALK will allow us to provide complete allergy management resources to veterinary dermatologists and general practitioners alike. By leveraging the expertise of both companies, we will enhance and expand the ACTT® Allergy Management program to provide the most comprehensive resource for allergy testing and treatment in the industry. Dr. Keesee and I are thrilled to become part of the ALK team," stated Pamela Blaine, Director of Marketing for Bio-Medical Services.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment